Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies.
Publication
, Preprint
Yazdani, A; Yazdani, A; Mendez-Giraldez, R; Pillonetto, G; Samiei, E; Hadi, R; Lenz, H-J; Venook, A; Samiei, A; Nixon, A; Lucci, J; Kopetz, S ...
March 11, 2024
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Yazdani, A., Mendez-Giraldez, R., Pillonetto, G., Samiei, E., Hadi, R., Lenz, H.-J., … Innocenti, F. (2024). Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies. https://doi.org/10.21203/rs.3.rs-4047331/v1
Yazdani, Akram, Azam Yazdani, Raul Mendez-Giraldez, Gianluigi Pillonetto, Esmat Samiei, Reza Hadi, Heinz-Josef Lenz, et al. “Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies.,” March 11, 2024. https://doi.org/10.21203/rs.3.rs-4047331/v1.
Yazdani A, Mendez-Giraldez R, Pillonetto G, Samiei E, Hadi R, Lenz H-J, et al. Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies. 2024.
Yazdani, Akram, et al. Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies. 11 Mar. 2024. Pubmed, doi:10.21203/rs.3.rs-4047331/v1.
Yazdani A, Mendez-Giraldez R, Pillonetto G, Samiei E, Hadi R, Lenz H-J, Venook A, Samiei A, Nixon A, Lucci J, Kopetz S, Bertagnolli M, Perou C, Innocenti F. Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies. 2024.